HIV/COVID-19 Mini-Residency-April 2022
At the conclusion of this activity, participants should be able to:
- Describe current trends in HIV epidemiology in the United States;
- Discuss the fundamentals and new trends in HIV prevention, testing, and counseling, including the use of PrEP and ART for prevention;
- List the classes and targets of anti-retroviral drugs, their side effects, and their indications for use;
- Review ART management in consideration of the prevention and effective management of common HIV co-morbidities, including depression, chronic kidney disease, cardiovascular disease, and HIV-associated neurological defects;
- Cite factors leading to drug resistance and three ways to reduce the risk of drug resistance;
- Recall current statistics surrounding COVID-19, mortality, and its degree of severity among adults;
- Discuss the current understanding of the COVID-19 pandemic including treatment and vaccines;
- Identify key elements of ambulatory HIV care via virtual encounters, including respectful engagement, sensitive history taking, limited physical diagnosis, laboratory management and clinical monitoring, and patient education;
- Describe strategies for HIV management during pregnancy to prevent mother-to-child transmission.
WANT TO KNOW MORE?
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at (312) 996-1413 or via email at email@example.com.
The University of Chicago reserves the right to cancel or postpone this activity due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTORS
Professor of Medicine
Aniruddha Hazra, MD
Assistant Professor of Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
University of Chicago Medicine is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This live activity is designated for a maximum of 15.25 continuing nursing education unit
Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.